SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056233
Filing Date
2021-11-10
Accepted
2021-11-10 16:32:18
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktx-10q_20210930.htm   iXBRL 10-Q 2859854
2 EX-10.2 nktx-ex102_80.htm EX-10.2 76730
3 EX-31.1 nktx-ex311_9.htm EX-31.1 19959
4 EX-31.2 nktx-ex312_7.htm EX-31.2 19287
5 EX-32 nktx-ex321_8.htm EX-32.1 14929
  Complete submission text file 0001564590-21-056233.txt   8028828

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nktx-20210930.xsd EX-101.SCH 39602
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktx-20210930_cal.xml EX-101.CAL 48615
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktx-20210930_def.xml EX-101.DEF 128292
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktx-20210930_lab.xml EX-101.LAB 347822
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktx-20210930_pre.xml EX-101.PRE 254613
11 EXTRACTED XBRL INSTANCE DOCUMENT nktx-10q_20210930_htm.xml XML 1329570
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 211397200
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences